U.S. markets close in 8 minutes
  • S&P 500

    4,136.72
    -26.54 (-0.64%)
     
  • Dow 30

    33,820.53
    -257.10 (-0.75%)
     
  • Nasdaq

    13,793.42
    -121.35 (-0.87%)
     
  • Russell 2000

    2,183.52
    -48.48 (-2.17%)
     
  • Crude Oil

    62.61
    -0.77 (-1.21%)
     
  • Gold

    1,778.10
    +7.50 (+0.42%)
     
  • Silver

    25.86
    +0.03 (+0.11%)
     
  • EUR/USD

    1.2044
    +0.0003 (+0.02%)
     
  • 10-Yr Bond

    1.5620
    -0.0390 (-2.44%)
     
  • GBP/USD

    1.3938
    -0.0046 (-0.33%)
     
  • USD/JPY

    108.0640
    -0.0860 (-0.08%)
     
  • BTC-USD

    56,581.48
    +862.43 (+1.55%)
     
  • CMC Crypto 200

    1,292.15
    +57.73 (+4.68%)
     
  • FTSE 100

    6,859.87
    -140.21 (-2.00%)
     
  • Nikkei 225

    29,100.38
    -584.99 (-1.97%)
     

10x Genomics to Present at the 41st Annual Cowen Health Care Conference

  • Oops!
    Something went wrong.
    Please try again later.
10x Genomics
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

PLEASANTON, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming 41st Annual Cowen Health Care Conference.

10x Genomics’ management is scheduled to present on Wednesday, March 3 at 2 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.10xgenomics.com/.

About 10x Genomics
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2019 based on publications and all of the top 20 global pharmaceutical companies by 2019 research and development spend, and have been cited in over 2,200 research papers on discoveries ranging from oncology to immunology and neuroscience. The company’s patent portfolio comprises more than 1,000 issued patents and patent applications.

Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts

Investors: investors@10xgenomics.com

Media: media@10xgenomics.com